Related Experiment Video

Updated: May 16, 2026

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

Methylation of tumor suppressor genes in ovarian cancer

Filiz Ozdemir1, Julide Altinisik, Ates Karateke

  • 1Department of Medical Biology, Istanbul University, Cerrahpasa Medical Faculty;

Experimental and Therapeutic Medicine
|December 11, 2012
PubMed

Insights

Aberrant DNA methylation inactivates tumor suppressor genes in ovarian cancer. CDKN2B, CDH13, and RASSF1 were most frequently methylated, suggesting their potential as biomarkers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Aberrant gene promoter methylation is a key mechanism for tumor suppressor gene inactivation in cancers.
  • Ovarian cancer exhibits complex genetic alterations, including epigenetic modifications.

Purpose of the Study:

  • To analyze the methylation patterns of 24 tumor suppressor genes in ovarian cancer tissues.
  • To identify frequently methylated genes and assess their potential as diagnostic or prognostic markers.

Main Methods:

  • Methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA) assay was used.
  • Analyzed 75 ovarian cancer samples and matched normal DNA.
  • Investigated methylation status of 24 specific tumor suppressor genes.

Main Results:

  • Aberrant methylation was detected in 17 out of 24 genes studied.
  • CDKN2B (24%), CDH13, and RASSF1 were the most frequently methylated genes.
  • Clear cell carcinoma showed a higher frequency of CDKN2B promoter hypermethylation (P=0.05).

Conclusions:

  • CDKN2B methylation is a frequent event in ovarian carcinogenesis.
  • Analysis of a few key genes, like CDKN2B, can detect methylation in a significant portion of ovarian cancers.
  • Further research with larger cohorts is needed to validate DNA methylation as a reliable biomarker for ovarian cancer.

More Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Related Concept Videos

Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...